Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 9 recruiting now full pipeline small index

Status Epilepticus: full-pipeline trial registry

9 of 11 indexed Status Epilepticus trials are currently recruiting.

Corpus placement: #1,577 of 28,707 conditions by registered trial count.

11 US clinical trials · 9 currently recruiting · #1,577 of 28,707 conditions by registered trial count

Status Epilepticus: 11 US clinical trials tracked, 9 recruiting.

Status Epilepticus is the subject of 11 registered US clinical trials on ClinicalTrials.gov, 9 of them currently open to new participants. 2 are in Phase 3-4 (later-stage) and 2 in Phase 1-2 (earlier-stage). The most active sponsor is University of California, San Francisco, running 2 of these trials.

Enrollment posture brief

Registry condition status-epilepticus

OPEN 9 | RECR 82% | LATE 2 | EARLY 2 | RANK #1577 | SPON 2

Nearest open-share peer: Gynecologic Cancers (82% recruiting · 11 trials)

Status Epilepticus (this)82%Acute Pancreatitis81.8%Acute Stroke45.5%Acquired Brain Injury36.4%Acute Lung Injury9.1%
Open-enrollment share among volume-matched conditions near Status Epilepticus

Status Epilepticus lists 9 open slots (82% of 11 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Status Epilepticus on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Status Epilepticus is recruiting above its size-band peers.

    9 of 11 indexed trials (81.8%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. One sponsor concentrates Status Epilepticus research.

    University of California, San Francisco accounts for 2 of 11 trials (18.2%). 10 distinct sponsors appear on at least one study for this condition label.

  3. Typical Status Epilepticus enrolment sits around 450 participants.

    Median target enrolment is 450 among the 11 trials that report a genuine target (sentinel values excluded). 4 of those (36.4%) plan for fewer than 100 participants.

  4. Status Epilepticus splits between interventional and observational designs.

    7 interventional and 4 observational studies make up this index (63.6% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 22Phase 32

Open and recent trials

11 total, page 1 of 1

RECRUITING 20,000 participants

De-identified UNMH EEG Corpus Database Creation With Fully De-identified Clinical Information

University of New Mexi

NCT05140265

RECRUITING 5,000 participants

Improving Outcomes for Patients With Life-Threatening Neurologic Illness

University of Maryland, Baltimore

NCT04189471

RECRUITING Phase 3 770 participants

Ketamine add-on Therapy for Established Status Epilepticus Treatment Trial (KESETT)

University of Virginia

NCT06907173

RECRUITING 512 participants

Augmented Renal Clearance in Neurocritical Care

University of Alberta

NCT07410624

RECRUITING NA 450 participants

Improving Status Epilepticus Treatment Times

Nationwide Children's Hospital

NCT06194747

RECRUITING NA 420 participants

Simulation Trial of Telemedical Support for Paramedics

Boston Medical Center

NCT06441760

RECRUITING 60 participants

Rapid-Response EEG in Children With Suspected Status Epilepticus

Children's Hospital at Montefiore

NCT06564662

RECRUITING Phase 2 52 participants

PeRampanel fOr Status ePilEpticus pRophylaxis Post-cardiac Arrest

University of California, San Francisco

NCT06401707

RECRUITING Phase 2 30 participants

buRst-supprESsion TO Stop Refractory Status Epilepticus Post-cardiac Arrest

University of California, San Francisco

NCT05851391

COMPLETED Phase 3 1,023 participants

Paramedic Treatment of Prolonged Seizures by Intramuscular Versus Intravenous Anticonvulsant Medications

Robert Silbergleit

NCT00809146

COMPLETED NA 17 participants

Seizure Rescue Medication: Caregiver Education in a Simulation Setting

Boston Children's Hospital

NCT03562351

Phase Distribution

PhaseTrial count
Phase 2 2
Phase 3 2

Named interventions

Most-linked intervention names on Status Epilepticus records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Mannequin Educational Intervention Other
1 trials
Video Educational Intervention Other
1 trials
Verbal Instructions Educational Intervention Other
1 trials
Intravenous route of active treatment Drug
1 trials
Intramuscular route of active treatment Drug
1 trials
Seizure Suppression EEG Target Intravenous Anesthesia Drug
1 trials
Burst Suppression EEG Target Intravenous Anesthesia Drug
1 trials
Levetiracetam (LEV) (60 mg/Kg) Drug
1 trials

US sites by state

Facility locations filed on Status Epilepticus trials. A trial with sites in several states counts in each.

Ohio 4 trials
California 4 trials
New York 3 trials
Massachusetts 3 trials
Michigan 2 trials
Maryland 2 trials
Kentucky 2 trials
Georgia 2 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Status Epilepticus page

11 registered trials, 9 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Status Epilepticus condition card totals 11 registered trials; most-linked intervention Mannequin Educational Intervention; top US site state Ohio. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.